Conclusively, our findings provided clinical information and a potential mechanism supporting that KLF4 negatively regulate lung cancer cell growth and hTERT expression in vivo and in vitro via MAPK signal pathway, and the novel KLF4/hTERT/MAPK pathway may become a potential target for treating lung cancer in the future. The gene discussed is KLF4; the disease is lung cancer.